# Avery Dennison Corp: Form 10-Q for the period ended Sep 28, 2019

- Company: [Avery Dennison Corp](/companies/avy.md) (CIK 8818)
- Form: 10-Q
- Filed: 2019-10-29
- Accepted by EDGAR: Oct 29, 2019, 15:01 ET
- Period: 2019-09-28
- Accession: 0001104659-19-057234
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/8818/000110465919057234/avy-20190928x10q3340d8.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/8818/000110465919057234/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-28.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-06-30 to 2019-09-28 | $1.76bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-12-30 to 2019-09-28 | $5.30bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-06-30 to 2019-09-28 | $1.29bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2018-12-30 to 2019-09-28 | $3.88bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-06-30 to 2019-09-28 | $471.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-12-30 to 2019-09-28 | $1.42bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2019-06-30 to 2019-09-28 | $265.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2018-12-30 to 2019-09-28 | $807.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2019-06-30 to 2019-09-28 | $19.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2018-12-30 to 2019-09-28 | $58.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-06-30 to 2019-09-28 | $34.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-12-30 to 2019-09-28 | −$58.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-06-30 to 2019-09-28 | $144.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-12-30 to 2019-09-28 | $141.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-06-30 to 2019-09-28 | $1.71 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-12-30 to 2019-09-28 | $1.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-06-30 to 2019-09-28 | $1.72 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-12-30 to 2019-09-28 | $1.68 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-06-30 to 2019-09-28 | 84,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-12-30 to 2019-09-28 | 85,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-12-30 to 2019-09-28 | $467.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-12-30 to 2019-09-28 | $132.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2018-12-30 to 2019-09-28 | $141.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2018-12-30 to 2019-09-28 | $204.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-09-28 | $224.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-28 | $2.33bn | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-28 | $5.34bn | us-gaap:Assets |
| Current liabilities | at 2019-09-28 | $2.27bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2019-09-28 | $514.2m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2019-09-28 | $1.06bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 45,289 characters.

Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations and should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and notes thereto.

### NON-GAAP FINANCIAL MEASURES

We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessment of our performance and operating trends, as well as liquidity.

Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, both positive or negative, of certain items (e.g., restructuring charges, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.

We use the following non-GAAP financial measures in this MD&A:

- *Organic sales change* refers to the increase or decrease in net sales excluding the estimated impact of foreign currency translation and, where applicable, the currency adjustment for transitional reporting of highly inflationary economies (Argentina). Segment results are also adjusted for the reclassification of sales between segments; the estimated impact of product line exits, acquisitions and divestitures; and, where applicable, the extra week in our fiscal year. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of foreign currency fluctuations. We believe that organic sales change assists investors in evaluating the sales change from the ongoing activities of our businesses and enhances their ability to evaluate our results from period to period.
- *Free cash flow* refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for our cash contributions related to the termination of our U.S. pension plan. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions.
- *Operational working capital as a percentage of annualized current quarter net sales* refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as net current assets or liabilities held-for-sale, divided by annualized current quarter net sales. We believe that operational working capital as a percentage of annualized current quarter net sales assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets, and other current liabilities) that tend to be disparate in amount, frequency, or timing, and that may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect underlying trends in our operations.

### OVERVIEW AND OUTLOOK

### Net Sales

The factors impacting reported net sales change, as compared to the prior year periods, are shown in the table below.

| ​ ​ ​ ​ | ​ ​ | ​ ​ Three Months Ended September 28, 2019 | ​ ​ Nine Months Ended September 28, 2019 |
| --- | --- | ---: | ---: |
| Reported net sales change | ​ | —% | (2)% |
| Foreign currency translation | ​ | 2 ​ | 4 ​ |
| Organic sales change | ​ | 2% | 2% |

In the third quarter of 2019, net sales increased on an organic basis as compared to the same period in the prior year primarily due to higher volume/mix. In the nine months ended September 28, 2019, net sales increased on an organic basis as compared to the same period in the prior year primarily due to prior year pricing actions.

### Net Income

Net income decreased by approximately $229 million in the first nine months of 2019 compared to the same period last year. Major factors affecting the change in net income included the following:

- Pension plan settlement charges, net of tax benefits related to effective settlement of U.S. pension plan
- Higher employee-related costs
- Impact of foreign currency translation

Offsetting factors:

- Benefits from productivity initiatives, including savings from restructuring actions, net of transition costs
- Net impact of pricing and raw material costs

### Cost Reduction Actions

#### 2018/2019 Actions

In April 2018, we approved a restructuring plan (the “2018 Plan”) to consolidate the European footprint of our Label and Graphic Materials (“LGM”) reportable segment, which is expected to reduce headcount by approximately 400 positions from the closure of a manufacturing facility. This reduction is expected to be partially offset by headcount additions in other locations, resulting in a net reduction of approximately 150 positions. The cumulative charges associated with the 2018 Plan through the third quarter of 2019 consisted of severance and related costs for the reduction of approximately 345 positions, as well as asset impairment charges. During the nine months ended September 28, 2019, we recorded a net $.8 million in restructuring reversals related to the 2018 Plan. The activities related to the 2018 Plan were substantially completed as of the end of the second quarter of 2019.

In addition to the net restructuring charges recorded under the 2018 Plan, we recorded $23 million in restructuring charges during the nine months ended September 28, 2019 related to other 2018/2019 Actions. These charges consisted of severance and related costs for the reduction of approximately 320 positions, as well as asset impairment charges and lease cancellation costs.

#### 2015/2016 Actions

During the nine months ended September 28, 2019, we recorded $.7 million in restructuring reversals related to restructuring actions initiated during the third quarter of 2015.

The activities and related charges and payments related to the 2015/2016 Actions were substantially completed in 2018.

#### Impact of Cost Reduction Actions

We anticipate savings from cost reduction actions, net of transition costs, of $50 million in 2019.

Restructuring charges were included in “Other expense (income), net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 7, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### U.S. Pension Plan Termination

In July 2018, our Board of Directors (“Board”) approved the termination of the Avery Dennison Pension Plan (the “ADPP”), a U.S. defined benefit plan, effective as of September 28, 2018. In connection with the termination, we contributed $200 million to the ADPP in August 2018 using U.S. commercial paper borrowings (subsequently repaid by the issuance of long-term debt); settled approximately $152 million of ADPP liabilities during the fourth quarter of 2018 through lump-sum payments from existing plan assets to eligible participants who elected to receive them; and recorded approximately $85 million of non-cash charges associated with these settlements. On March 21, 2019, we effectively settled the remaining ADPP liabilities through the execution of an agreement to purchase annuities from American General Life Insurance Company (“AGL”), a subsidiary of American International Group, Inc. Under the agreement, we settled approximately $750 million of ADPP pension obligations for approximately 8,500 active and former employees and their beneficiaries, with AGL assuming the future annuity payments for these individuals, commencing at April 1, 2019. This settlement resulted in approximately $447 million of pretax charges, partially offset by related tax benefits of $180 million, which we recorded in March 2019. Refer to Note 5, "Pension and Other Postretirement Benefits," to the unaudited Condensed Consolidated Financial Statements for more information.

### Accounting Guidance Updates

Refer to Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Cash Flow

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net cash provided by operating activities | ​ | $467.0 | ​ | $187.7 |
| Purchases of property, plant and equipment | ​ | (132.9) | ​ | (132.7) |
| Purchases of software and other deferred charges | ​ | (27.4) | ​ | (21.5) |
| Proceeds from sales of property, plant and equipment | ​ | 7.7 | ​ | 9.4 |
| Proceeds from insurance and (purchases) sales of investments, net | ​ | 3.5 | ​ | 17.6 |
| Pension plan contributions for plan termination | ​ | 9.5 | ​ | 200.0 |
| Free cash flow | ​ | $327.4 | ​ | $260.5 |

During the first nine months of 2019, net cash provided by operating activities increased compared to the same period last year primarily due to lower pension plan contributions, improved working capital, and lower incentive compensation payments, partially offset by higher restructuring payments related to our 2018/2019 Actions. During the first nine months of 2019, free cash flow increased compared to the same period last year due to an increase in net cash provided by operating activities adjusted for our ADPP contributions.

### Outlook

Certain factors that we believe may contribute to our 2019 results are described below:

- We expect our net sales, including the effects of foreign currency translation, to decline by 1.1% to 1.4%.
- Assuming the continuation of current foreign currency rates, we expect currency translation to reduce our pretax operating income by approximately $37 million.
- We expect our full year effective tax rate to be in the single-digit range.
- We estimate savings of $50 million from restructuring actions, net of transition costs.
- We anticipate capital and software expenditures of $270 million to $280 million.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE THIRD QUARTER

### Income Before Taxes

*(In millions, except percentages)*

| ​ ​ | ​ ​ | ​ ​ ​ Three Months Ended September 28, 2019 | ​ ​ ​ September 29, 2018 ​ |
| --- | --- | ---: | ---: |
| Net sales | ​ | $1,761.4 ​ | $1,759.7 ​ |
| Cost of products sold | ​ | 1,289.7 ​ | 1,300.5 ​ |
| Gross profit | ​ | 471.7 ​ | 459.2 ​ |
| Marketing, general and administrative expense | ​ | 265.3 ​ | 270.5 ​ |
| Other expense (income) net | ​ | 6.7 ​ | (3.0) ​ |
| Interest expense | ​ | 19.0 ​ | 14.7 ​ |
| Other non-operating expense | ​ | .8 ​ | 9.0 ​ |
| Income before taxes | ​ | $179.9 ​ | $168.0 ​ |
| ​ | ​ | ​ ​ ​ | ​ ​ ​ |
| Gross profit margin | ​ | 26.8% | 26.1% |

#### Gross Profit Margin

Gross profit margin percentage for the third quarter of 2019 increased compared to the same period last year primarily reflecting benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, partially offset by higher employee-related costs.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense decreased in the third quarter of 2019 compared to the same period last year reflecting benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and the favorable impact of foreign currency translation, partially offset by higher employee-related costs and growth-related investments.

#### Other Expense (Income), net

*(In millions)*

| ​ ​ Other expense (income), net by type Restructuring charges: | ​ ​ | ​ ​ Three Months Ended September 28, 2019 ​ ​ | ​ | ​ ​ September 29, 2018 ​ ​ |
| --- | --- | ---: | --- | ---: |
| Severance and related costs, net of reversals | ​ | $3.3 | ​ | $(7.1) |
| Asset impairment charges and lease cancellation costs | ​ | — | ​ | .7 |
| Other items: | ​ | ​ | ​ |  |
| Legal settlement | ​ | 3.4 | ​ | — |
| Argentine peso remeasurement transition loss | ​ | — | ​ | 3.4 |
| Other expense (income), net | ​ | $6.7 | ​ | $(3.0) |

Refer to Note 7, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.

#### Interest Expense

Interest expense increased in the third quarter of 2019 compared to the same period last year reflecting additional interest costs related to the $500 million of senior notes we issued in December 2018.

#### Other Non-Operating Expense

Other non-operating expense decreased in the third quarter of 2019 compared to the same period last year primarily due to lower pension plan settlements and related charges.

### Net Income and Earnings per Share

*(In millions, except per share amounts and percentages)*

| ​ ​ | ​ ​ | ​ ​ ​ Three Months Ended September 28, 2019 | ​ ​ ​ ​ September 29, 2018 ​ |
| --- | --- | ---: | ---: |
| Income before taxes | ​ | $179.9 ​ | $168.0 ​ |
| Provision for income taxes | ​ | 34.6 ​ | 17.7 ​ |
| Equity method investment losses | ​ | (.7) ​ | (.8) ​ |
| Net income | ​ | $144.6 ​ | $149.5 ​ |
| Per share amounts: | ​ | ​ ​ | ​ ​ |
| Net income per common share | ​ | $1.72 ​ | $1.71 ​ |
| Net income per common share, assuming dilution | ​ | 1.71 ​ | 1.69 ​ |
| ​ | ​ | ​ ​ ​ | ​ ​ ​ |
| Effective tax rate | ​ | 19.2% | 10.5% |

#### Provision for Income Taxes

Our effective tax rate for the three months ended September 28, 2019 was 19.2%, compared to 10.5% in the same period last year. The increase in tax rate was primarily due to lower discrete tax benefits recognized in the three months ended September 28, 2019. Refer to Note 9, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE THIRD QUARTER

Operating income refers to income before taxes, interest and other non-operating expenses.

### Label and Graphic Materials

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Three Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net sales including intersegment sales | ​ | $1,203.3 | ​ | $1,215.1 |
| Less intersegment sales | ​ | (18.2) | ​ | (20.9) |
| Net sales | ​ | $1,185.1 | ​ | $1,194.2 |
| Operating income(1) | ​ | 159.0 | ​ | 152.9 |
| ​ | ​ | ​ ​ | ​ | ​ ​ |
| (1)Included charges associated with restructuring, net of reversals, in both years and Argentine peso remeasurement transition loss in 2018 | ​ | $1.2 | ​ | $(6.0) |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

| ​ ​ ​ ​ ​ | ​ ​ Three Months Ended ​ September 28, 2019 ​ |
| --- | ---: |
| Reported net sales change | (1)% |
| Reclassification of sales between segments | — ​ |
| Foreign currency translation | 2 ​ |
| Organic sales change | 1% |

In the third quarter of 2019, net sales increased on an organic basis compared to the same period in the prior year primarily due to higher volume/mix. On an organic basis, net sales increased by low-single digit rates in Western Europe and emerging markets and were flat in North America.

#### Operating Income

Operating income increased in the third quarter of 2019 compared to the same period last year primarily due to benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, partially offset by higher restructuring charges and employee-related costs.

### Retail Branding and Information Solutions

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Three Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net sales including intersegment sales | ​ | $412.4 | ​ | $399.7 |
| Less intersegment sales | ​ | (5.6) | ​ | (1.3) |
| Net sales | ​ | $406.8 | ​ | $398.4 |
| Operating income(1) | ​ | 45.7 | ​ | 42.4 |
| ​ | ​ | ​ ​ | ​ | ​ ​ |
| (1)Included charges associated with restructuring in both years | ​ | $1.2 | ​ | $3.0 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

| ​ ​ ​ ​ ​ | ​ ​ Three Months Ended September 28, 2019 |
| --- | ---: |
| Reported net sales change | 2% |
| Reclassification of sales between segments | — ​ |
| Foreign currency translation | 2 ​ |
| Organic sales change | 4% |

In the third quarter of 2019, net sales increased on an organic basis compared to the same period in the prior year primarily due to continued strength in radio-frequency identification solutions, partially offset by a decline in the base business.

#### Operating Income

Operating income increased in the third quarter of 2019 compared to the same period last year primarily due to benefits from productivity initiatives, higher volume and lower restructuring charges, partially offset by higher employee-related costs and growth-related investments.

### Industrial and Healthcare Materials

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Three Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net sales including intersegment sales | ​ | $171.0 | ​ | $169.7 |
| Less intersegment sales | ​ | (1.5) | ​ | (2.6) |
| Net sales | ​ | $169.5 | ​ | $167.1 |
| Operating income(1) | ​ | 17.7 | ​ | 15.3 |
| ​ | ​ | ​ ​ | ​ | ​ ​ |
| (1)Included charges associated with restructuring in 2019 | ​ | $.9 | ​ | $— |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

| ​ ​ ​ ​ ​ | ​ ​ Three Months Ended September 28, 2019 |
| --- | ---: |
| Reported net sales change | 1% |
| Foreign currency translation | 2 ​ |
| Organic sales change(1) | 4% |

(1) Total does not sum due to rounding

In the third quarter of 2019, net sales increased on an organic basis compared to the same period in the prior year due to a low-to mid-single digit increase in industrial categories and a high-single digit increase in healthcare categories.

#### Operating Income

Operating income increased in the third quarter of 2019 compared to the same period last year primarily due to benefits from higher volume/mix and productivity initiatives, including savings from restructuring actions, net of transition costs, partially offset by higher restructuring and employee-related costs.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE NINE MONTHS YEAR-TO-DATE

### Income Before Taxes

*(In millions, except percentages)*

| ​ ​ | ​ ​ | ​ ​ ​ Nine Months Ended September 28, 2019 | ​ ​ ​ September 29, 2018 |
| --- | --- | ---: | ---: |
| Net sales | ​ | $5,297.2 ​ | $5,390.3 ​ |
| Cost of products sold | ​ | 3,877.8 ​ | 3,946.3 ​ |
| Gross profit | ​ | 1,419.4 ​ | 1,444.0 ​ |
| Marketing, general and administrative expense | ​ | 807.3 ​ | 853.0 ​ |
| Other expense, net | ​ | 21.7 ​ | 66.9 ​ |
| Interest expense | ​ | 58.0 ​ | 42.2 ​ |
| Other non-operating expense | ​ | 448.2 ​ | 14.9 ​ |
| Income before taxes | ​ | $84.2 ​ | $467.0 ​ |
| ​ | ​ | ​ ​ ​ | ​ ​ ​ |
| Gross profit margin | ​ | 26.8% | 26.8% |

#### Gross Profit Margin

Gross profit margin for the first nine months of 2019 was flat compared to the same period last year, reflecting benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, offsetting the net impact of higher selling prices to cover raw material inflation and higher employee-related costs.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense decreased in the first nine months of 2019 compared to the same period last year reflecting the benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and the favorable impact of foreign currency translation, partially offset by higher employee-related costs.

#### Other Expense, net

*(In millions)*

| ​ ​ Other expense, net by type Restructuring charges: | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 ​ ​ | ​ | ​ ​ September 29, 2018 ​ ​ |
| --- | --- | ---: | --- | ---: |
| Severance and related costs, net of reversals | ​ | $19.8 | ​ | $56.0 |
| Asset impairment charges and lease cancellation costs | ​ | 1.7 | ​ | 9.7 |
| Other items: | ​ |  | ​ |  |
| Legal settlement | ​ | ​ 3.4 | ​ | ​ — |
| Argentine peso remeasurement transition loss | ​ | ​ — | ​ | ​ 3.4 |
| Other restructuring-related charge | ​ | — | ​ | .5 |
| Net gains on sale of assets | ​ | (3.2) | ​ | (2.7) |
| Other expense, net | ​ | $21.7 | ​ | $66.9 |

Refer to Note 7, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.

#### Interest Expense

Interest expense increased in the first nine months of 2019 compared to the same period last year reflecting additional interest costs related to the $500 million of senior notes we issued in December 2018.

#### Other Non-Operating Expense

Other non-operating expense increased in the first nine months of 2019 compared to the same period last year due to the settlement of the ADPP, which resulted in $447 million of pretax charges that were partially offset by related tax benefits of $180 million. Refer to Note 5, “Pension and Other Postretirement Benefits,” and Note 9, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Net Income and Earnings per Share

*(In millions, except per share amounts and percentages)*

| ​ ​ | ​ ​ | ​ ​ ​ Nine Months Ended September 28, 2019 | ​ ​ ​ September 29, 2018 |
| --- | --- | ---: | ---: |
| Income before taxes | ​ | $84.2 ​ | $467.0 ​ |
| (Benefit from) provision for income taxes | ​ | (58.9) ​ | 94.9 ​ |
| Equity method investment losses | ​ | (2.0) ​ | (1.8) ​ |
| Net income | ​ | $141.1 ​ | $370.3 ​ |
| Per share amounts: | ​ | ​ ​ | ​ ​ |
| Net income per common share | ​ | $1.68 ​ | $4.22 ​ |
| Net income per common share, assuming dilution | ​ | 1.66 ​ | 4.16 ​ |
| ​ | ​ | ​ ​ ​ | ​ ​ ​ |
| Effective tax rate | ​ | (70.0)% | 20.3% |

#### Provision for Income Taxes

Our effective tax rate for the nine months ended September 28, 2019 was (70.0)% compared to 20.3% in the same period last year. The decrease in tax rate was primarily due to the tax effects of the settlement charges associated with the termination of the ADPP in March 2019, partially offset by lower discrete tax benefits recognized in the nine months ended September 28, 2019. Refer to Note 9, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.

We currently expect our effective tax rate for 2019 to be in the single-digit range. Our effective tax rate can vary from quarter to quarter due to the recognition of discrete events, such as changes in tax reserves, settlements of income tax audits, changes in tax laws and regulations, return-to-provision adjustments, tax impacts related to stock-based payments, as well as recurring factors, such as changes in the mix of earnings in countries with differing statutory tax rates and the execution of tax planning strategies. We continue to pursue planning opportunities in certain foreign jurisdictions primarily to react to the loss of concessionary tax rates. We believe that we are on track to realize these opportunities. We continue to evaluate certain key factors that may significantly influence the amount of benefit to be recognized in 2019.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE NINE MONTHS YEAR-TO-DATE

Operating income refers to income before taxes, interest and other non-operating expenses.

### Label and Graphic Materials

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net sales including intersegment sales | ​ | $3,629.2 | ​ | $3,729.3 |
| Less intersegment sales | ​ | (59.5) | ​ | (59.6) |
| Net sales | ​ | $3,569.7 | ​ | $3,669.7 |
| Operating income(1) | ​ | 460.6 | ​ | 418.1 |
| ​ | ​ | ​ ​ | ​ | ​ ​ |
| (1)Included charges associated with restructuring, net of reversals, in both years, and Argentine peso remeasurement transition loss, other restructuring-related charge and loss on sale of assets in 2018 | ​ | $13.2 | ​ | $59.9 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

| ​ ​ ​ ​ ​ | ​ ​ Nine Months Ended ​ September 28, 2019 ​ |
| --- | ---: |
| Reported net sales change | (3)% |
| Reclassification of sales between segments | — ​ |
| Foreign currency translation | 4 ​ |
| Organic sales change | 1% |

In the first nine months of 2019, net sales increased on an organic basis compared to the same period in the prior year due to prior year pricing actions partially offset by lower volume/mix. On an organic basis, net sales were up low-single digits in emerging markets and flat in North America and Western Europe.

#### Operating Income

Operating income increased in the first nine months of 2019 compared to the same period last year primarily due to lower restructuring charges and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, partially offset by the unfavorable impact of foreign currency translation and lower volume/mix.

### Retail Branding and Information Solutions

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net sales including intersegment sales | ​ | $1,238.2 | ​ | $1,204.0 |
| Less intersegment sales | ​ | (14.8) | ​ | (2.9) |
| Net sales | ​ | $1,223.4 | ​ | $1,201.1 |
| Operating income(1) | ​ | 147.5 | ​ | 122.4 |
| ​ | ​ | ​ ​ | ​ | ​ ​ |
| (1)Included charges associated with restructuring and net gain on sales of assets in both years. | ​ | $.9 | ​ | $9.1 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

| ​ ​ ​ ​ ​ | ​ ​ Nine Months Ended September 28, 2019 |
| --- | ---: |
| Reported net sales change | 2% |
| Reclassification of sales between segments | — ​ |
| Foreign currency translation | 3 ​ |
| Organic sales change | 5% |

In the first nine months of 2019, net sales increased on an organic basis compared to the same period in the prior year primarily due to continued strength in radio-frequency identification solutions.

#### Operating Income

Operating income increased in the first nine months of 2019 compared to the same period last year primarily due to higher volume, benefits from productivity initiatives, including savings from restructuring actions, net of transition costs and lower restructuring charges, partially offset by higher employee-related costs.

### Industrial and Healthcare Materials

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net sales including intersegment sales | ​ | $511.1 | ​ | $526.3 |
| Less intersegment sales | ​ | (7.0) | ​ | (6.8) |
| Net sales | ​ | $504.1 | ​ | $519.5 |
| Operating income(1) | ​ | 47.8 | ​ | 44.9 |
| ​ | ​ | ​ ​ | ​ | ​ ​ |
| (1)Included charges associated with restructuring in both years | ​ | $4.2 | ​ | $.2 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

| ​ ​ ​ ​ ​ | ​ ​ Nine Months Ended September 28, 2019 |
| --- | ---: |
| Reported net sales change | (3)% |
| Foreign currency translation | 4 ​ |
| Organic sales change | 1% |

In the first nine months of 2019, net sales increased on an organic basis compared to the same period in the prior year due to a mid-single digit increase in healthcare categories and a low-single digit increase in industrial categories.

#### Operating Income

Operating income increased in the first nine months of 2019 compared to the same period last year primarily due to benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and the net benefit of pricing and raw material costs, partially offset by higher restructuring charges and higher employee-related costs.

### FINANCIAL CONDITION

### Liquidity

### Operating Activities

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net income | ​ | $141.1 | ​ | $370.3 |
| Depreciation and amortization | ​ | 133.4 | ​ | 136.0 |
| Provision for doubtful accounts and sales returns | ​ | 42.4 | ​ | 34.3 |
| Stock-based compensation | ​ | 25.5 | ​ | 24.8 |
| Pension plan settlements and related charges | ​ | 446.9 | ​ | 7.4 |
| Deferred income taxes and other non-cash taxes | ​ | (176.4) | ​ | (7.8) |
| Other non-cash expense and loss (income and gain), net | ​ | 17.5 | ​ | 47.4 |
| Changes in assets and liabilities and other adjustments | ​ | (163.4) | ​ | (424.7) |
| Net cash provided by operating activities | ​ | $467.0 | ​ | $187.7 |

For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in “Analysis of Selected Balance Sheet Accounts”).

During the first nine months of 2019, net cash provided by operating activities increased compared to the same period last year primarily due to lower pension plan contributions, improved operational working capital, and lower incentive compensation payments, partially offset by higher restructuring payments related to our 2018/2019 Actions.

### Investing Activities

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Purchases of property, plant and equipment | ​ | $(132.9) | ​ | $(132.7) |
| Purchases of software and other deferred charges | ​ | (27.4) | ​ | (21.5) |
| Proceeds from sales of property, plant and equipment | ​ | 7.7 | ​ | 9.4 |
| Proceeds from insurance and (purchases) sales of investments, net | ​ | 3.5 | ​ | 17.6 |
| Payments for investments in businesses | ​ | (6.5) | ​ | (.2) |
| Net cash used in investing activities | ​ | $(155.6) | ​ | $(127.4) |

#### Purchases of Property, Plant and Equipment

During the first nine months of 2019 and 2018, we invested in equipment to support growth in Asia, North America, and Europe and to improve manufacturing productivity.

#### Purchases of Software and Other Deferred Charges

During the first nine months of 2019, we invested in enterprise resource planning system implementations in North America and information technology upgrades worldwide. During the first nine months of 2018, we invested in information technology primarily associated with enterprise resource planning system implementations in North America and Asia.

#### Proceeds from Sales of Property, Plant and Equipment

During the first nine months of 2019, the majority of the proceeds from sales of property, plant and equipment was related to the sale of one property in each of North America, Asia and Europe. During the first nine months of 2018, the majority of the proceeds from sales of property, plant and equipment was related to the sale of two properties in Europe.

#### Proceeds from Insurance and (Purchases) Sales of Investments, Net

During the first nine months of 2019, we had lower proceeds from insurance associated with our corporate-owned life insurance policies and higher net purchases of investments compared to the same period last year.

#### Payments for Investments in Businesses

During the first nine months of 2019, we paid $6.5 million for investments in unconsolidated businesses.

### Financing Activities

*(In millions)*

| ​ ​ | ​ ​ | ​ ​ Nine Months Ended September 28, 2019 | ​ | ​ ​ September 29, 2018 |
| --- | --- | ---: | --- | ---: |
| Net increase in borrowings (maturities of three months or less) | ​ | $68.9 | ​ | $301.4 |
| Repayments of long-term debt and finance leases | ​ | (17.7) | ​ | (4.4) |
| Dividends paid | ​ | (141.3) | ​ | (130.6) |
| Share repurchases | ​ | (204.3) | ​ | (175.1) |
| Net (tax withholding) proceeds related to stock-based compensation | ​ | (17.4) | ​ | (31.9) |
| Payments of contingent consideration | ​ | (1.6) | ​ | (17.3) |
| Net cash used in financing activities | ​ | $(313.4) | ​ | $(57.9) |

#### Borrowings and Repayment of Debt

Given the seasonality of our cash flow from operating activities, during the first nine months of 2019 and 2018, our commercial paper borrowings were used to fund share repurchase activity, dividend payments, and capital expenditures, and for other general corporate purposes.

Refer to Note 4, “Debt” to the unaudited Condensed Consolidated Financial Statements for more information.

#### Dividends Paid

We paid dividends of $1.68 per share in the first nine months of 2019 compared to $1.49 per share in the same period last year. In April 2019, we increased our quarterly dividend to $.58 per share, representing an increase of approximately 12% from our previous dividend rate of $.52 per share.

#### Share Repurchases

During the first nine months of 2019 and 2018, we repurchased approximately 2 million and 1.6 million shares of our common stock, respectively.

In April 2019, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases, in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased.

As of September 28, 2019, shares of our common stock in the aggregate amount of $678.2 million remained authorized for repurchase under our outstanding Board authorizations.

#### Net (Tax Withholding) Proceeds Related to Stock-Based Compensation

During the first nine months of 2019, tax withholding for stock-based compensation decreased compared to the same period in 2018 as a result of equity awards vesting at lower share prices.

Approximately .3 million and .01 million stock options were exercised during the first nine months of 2019 and 2018, respectively.

#### Payments of Contingent Consideration

During the first nine months of 2019 and 2018, payments of contingent consideration were related to the achievement of certain performance targets by companies we acquired in 2017.

### Analysis of Selected Balance Sheet Accounts

#### Long-lived Assets

In the nine months ended September 28, 2019, goodwill decreased by approximately $21 million to $920 million due to the impact of foreign currency translation.

In the nine months ended September 28, 2019, other intangibles resulting from business acquisitions, net, decreased by approximately $15 million to $129 million, primarily reflecting current year amortization expense and the impact of foreign currency translation.

Refer to Note 3, “Goodwill,” to the unaudited Condensed Consolidated Financial Statements for more information.

In the nine months ended September 28, 2019, other assets increased by approximately $167 million to $618 million, which primarily reflected the capitalization of operating lease assets as a result of our adoption of the accounting guidance update described in Note 1, “General,” of the unaudited Condensed Consolidated Financial Statements. The increase in other assets also reflected additional investments in unconsolidated businesses.

#### Other Long-term Liabilities

In the nine months ended September 28, 2019, long-term retirement benefits and other liabilities increased by approximately $92 million to $427 million, primarily reflecting the recognition of operating lease liabilities as the result of our adoption of the accounting guidance update described in Note 1, “General,” of the unaudited Condensed Consolidated Financial Statements.

#### Shareholders’ Equity Accounts

As of September 28, 2019, the balance of our shareholders' equity was $1.06 billion. Refer to Note 11, “Supplemental Equity and Comprehensive Income Information,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Impact of Foreign Currency Translation

*(In millions)*

| ​ ​ ​ | ​ ​ ​ | ​ ​ ​ Nine Months Ended September 28, 2019 |
| --- | --- | ---: |
| Change in net sales | ​ | $(198) |

International operations generated approximately 77% of our net sales during the nine months ended September 28, 2019. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The unfavorable impact of foreign currency translation on net sales in the first nine months of 2019 compared to the same period last year was primarily related to euro-denominated sales and sales in China and Brazil.

In July 2018, we began accounting for our operations in Argentina as highly inflationary, as the country’s three-year cumulative inflation rate exceeded 100%. As a result, the functional currency of our Argentine subsidiary became the U.S. dollar.

### Effect of Foreign Currency Transactions

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. We also utilized certain foreign-currency-denominated debt to mitigate foreign currency translation exposure from our net investment in foreign operations. Refer to Note 8, “Financial Instruments,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Analysis of Selected Financial Ratios

We utilize the financial ratios discussed below to assess our financial condition and operating performance.

#### Operational Working Capital Ratio

Operational working capital, as a percentage of annualized current-quarter net sales, is reconciled to working capital below. Our objective is to minimize our investment in operational working capital, as a percentage of annualized current-quarter net sales, to maximize cash flow and return on investment. Operational working capital, as a percentage of annualized current-quarter net sales, in the third quarter of 2019, was lower compared to the third quarter of 2018.

*(In millions, except percentages)*

| ​ | ​ | ​ ​ ​ September 28, 2019 | ​ ​ ​ September 29, 2018 ​ |
| --- | --- | ---: | ---: |
| (A) Working capital | ​ | $65.5 ​ | $.6 ​ |
| Reconciling items: | ​ | ​ ​ | ​ ​ |
| Cash and cash equivalents | ​ | (224.2) ​ | (217.6) ​ |
| Other current assets | ​ | (220.0) ​ | (223.0) ​ |
| Short-term borrowings and current portion of long-term debt and finance leases | ​ | ​ 514.2 ​ | ​ 571.7 ​ |
| Accrued payroll and employee benefits and other current liabilities | ​ | 712.5 ​ | 738.5 ​ |
| (B) Operational working capital | ​ | $848.0 ​ | $870.2 ​ |
| (C) Third-quarter net sales, annualized | ​ | $7,045.6 ​ | $7,038.8 ​ |
| Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) | ​ | 12.0% | 12.4% |

#### Accounts Receivable Ratio

The average number of days sales outstanding was 63 days in the first nine months of 2019 and 2018, respectively, calculated using the average of the three quarter-end trade accounts receivable balances divided by the average daily sales for the first nine months.

#### Inventory Ratio

Average inventory turnover was 7.7 in the first nine months of 2019 and 7.8 in the first nine months of 2018, calculated using the annualized cost of sales (year-to-date cost of products sold, divided by three and multiplied by four) divided by the average of the three quarter-end inventory balances for the first nine months. The decrease in average inventory turnover primarily reflected the timing of inventory purchases.

#### Accounts Payable Ratio

The average number of days payable outstanding was 74 days in the first nine months of 2019 and 73 days in the first nine months of 2018, calculated using the average of the three quarter-end accounts payable balances divided by the average daily cost of products sold for the first nine months. The increase in the average number of days payable outstanding from the prior year primarily reflected longer payment terms with vendors and the impact of foreign currency translation.

### Capital Resources

Capital resources include cash flows from operations, cash and cash equivalents, and debt financing, including ready access to commercial paper. We use these resources to fund operational needs. At September 28, 2019, we had cash and cash equivalents of $224.2 million held in accounts at third-party financial institutions.

Our cash balances are held in numerous locations throughout the world. At September 28, 2019, the majority of our cash and cash equivalents was held by our foreign subsidiaries.

To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings and profits. However, if we were to repatriate incremental foreign earnings and profits, we may be subject to withholding taxes imposed by foreign tax authorities and additional U.S. taxes due to the impact of foreign currency movements related to these earnings and profits.

We have an $800 million revolving credit facility (the “Revolver”) that matures in November 2022. The Revolver is used as a back-up facility for our commercial paper program and can be used for other corporate purposes. The Revolver contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of September 28, 2019 and December 29, 2018, we were in compliance with our financial covenants.

We currently anticipate using commercial paper borrowings to repay approximately $265 million of notes maturing in the second quarter of 2020.

#### Capital from Debt

The carrying value of our total debt increased by approximately $32 million in the first nine months of 2019 to $2 billion, primarily reflecting a net increase in commercial paper borrowings to support operational needs.

Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, we expect that the Revolver and our other credit facilities would be available to meet our short-term funding requirements. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

### Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters

Refer to Note 13, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements. Except as indicated therein, we have no material off-balance sheet arrangements as described in Item 303 (a)(4) of Regulation S-K.

### RECENT ACCOUNTING REQUIREMENTS

Refer to Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements.

## Market risk

As filed, 228 characters.

There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 29, 2018 that have not been disclosed in our periodic filings with the SEC.

## Controls and procedures

As filed, 3,273 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Glendale, California. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

### Changes in Internal Control Over Financial Reporting

We periodically assess our internal control environment. During the third quarter of 2019, we continued the implementation of a new enterprise resource planning system in several locations of our Label and Graphic Materials (“LGM”) business in North America. Processes affected by this implementation include, among other things, order management, pricing, shipping and purchasing. Where appropriate, we have made changes to related internal controls over our financial reporting. By the end of 2019, we expect to complete the implementation in the remaining in-scope LGM locations in North America.

We are in the process of investing in information technology to upgrade the systems in our Retail Branding and Information Solutions reportable segment. Processes affected by this implementation include, among other things, general accounting and planning. Where appropriate, we are reviewing related internal controls and making changes.

There have been no other changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 229 characters.

There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 29, 2018 that have not been disclosed in our periodic filings with the SEC.

Filed Oct 29, 2019.
Source: SEC EDGAR, the filing index for accession 0001104659-19-057234. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.
